Dec 23, 2019

Drugmakers opt to mine medical data in lieu of lengthy clinical trials

Go deeper

Drug price hikes are back for 2020

Illustration: Sarah Grillo/Axios

Pharmaceutical manufacturers have raised the sticker prices on hundreds of drugs at the start of 2020, with most of the increases coming under 10%.

The big picture: It may be a new year, but the same drugs are once again subject to the same industry practices.

Go deeperArrowUpdated Jan 6, 2020

HHS' pending data-sharing rules spark fight over patient records

Alex Azar, secretary of HHS. Photo: Zach Gibson/Getty Images

There's an intense lobbying fight over Health and Human Services' pending health care data-sharing rules, Politico reports.

Between the lines: The fight involves hospitals, digital health firms and patient advocates.

Go deeperArrowJan 16, 2020

Federal mandate for publishing clinical trials wasn't enforced

Illustration: Rebecca Zisser/Axios

Federal officials are doing little or nothing to enforce a 2017 law that requires drugmakers and researchers to log their clinical trials into a federal database, according to an investigation published in Science.

Why it matters: The law was designed to give the public, along with outside researchers, more access to information about drugs' safety and efficacy.

Go deeperArrowJan 15, 2020